Zurich Cantonal Bank
TYRA icon

Zurich Cantonal Bank’s Tyra Biosciences TYRA Stock Holding History

Zurich Cantonal Bank’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
+8,038
New +$260K ﹤0.01% 2081
2025
Q2 		– Sell
-9,047
Closed -$84.1K – 2630
2025
Q1 		$84.1K Buy
+9,047
New +$117K ﹤0.01% 2440

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Zurich Cantonal Bank's TYRA Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 8,038 shares worth $308K. The stake represents ﹤0.01% of the portfolio and ranks #2081 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in TYRA as recently as Q1 2025.

Zurich Cantonal Bank first reported a position in TYRA in Q1 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Zurich Cantonal Bank held 8,038 shares of Tyra Biosciences worth $308K as of Q1 2026.
  • Tyra Biosciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2081 holding.
  • Zurich Cantonal Bank first reported a position in Tyra Biosciences in Q1 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.